Full Professor(heuristic)

Cancer Cells and Metastasis · Oncology

Compare more Oncology professors.

h-index73
i10-index165
Publications361
Citations18,508

Grants

15 total · 2 active

NIH #R01CA298883

Translational development of osteosarcoma (OS) extracellular vesicle (EV) matrix metalloproteinase (MMP) Activity Assay for assessing patient treatment responses

Active
Amount
$2M–$3M
Period
2025-09-01 → 2029-08-31
PIs
3

Awarded at UNIVERSITY OF CALIFORNIA LOS ANGELES

NIH #R01CA277530

Click Chemistry-Mediated Surface Protein Assay for Quantifying Subpopulations of Hepatocellular Carcinoma-associated Extracellular Vesicles

Active
Amount
$600K–$700K
Period
2023-07-01 → 2028-06-30
PIs
3

Awarded at UNIVERSITY OF CALIFORNIA LOS ANGELES

NIH #R44CA288163

Developing and Automating an Extracellular Vesicle-Based Test for Early Detection of Hepatocellular Carcinoma

Amount
$600K–$700K
Period
2023-09-14 → 2026-08-31
PIs
3

Awarded at EXIMIUS DIAGNOSTICS CORP

Active grants are a starting point, not proof of an opening. Confirm recruiting and funding with the professor, current students, and your written offer. Learn how to verify PhD funding →

All Grants

15 total · 2 active

NIH #R01CA298883

Translational development of osteosarcoma (OS) extracellular vesicle (EV) matrix metalloproteinase (MMP) Activity Assay for assessing patient treatment responses

Active
Amount
$2M–$3M
Period
2025-09-01 → 2029-08-31
PIs
3

Awarded at UNIVERSITY OF CALIFORNIA LOS ANGELES

NIH #R01CA277530

Click Chemistry-Mediated Surface Protein Assay for Quantifying Subpopulations of Hepatocellular Carcinoma-associated Extracellular Vesicles

Active
Amount
$600K–$700K
Period
2023-07-01 → 2028-06-30
PIs
3

Awarded at UNIVERSITY OF CALIFORNIA LOS ANGELES

NIH #R44CA288163

Developing and Automating an Extracellular Vesicle-Based Test for Early Detection of Hepatocellular Carcinoma

Amount
$600K–$700K
Period
2023-09-14 → 2026-08-31
PIs
3

Awarded at EXIMIUS DIAGNOSTICS CORP

NIH #R01CA253651

Covalent Chemistry on Nanosubstrates Enables Molecular Analysis of Purified Extracellular Vesicles in Hepatocellular Carcinoma

Amount
$700K–$800K
Period
2020-07-07 → 2026-06-30
PIs
3

Awarded at UNIVERSITY OF CALIFORNIA LOS ANGELES

NIH #R01CA246304

Integrated analysis of HCC CTCs for Liver Transplant Candidate Selection

Amount
$600K–$700K
Period
2020-04-01 → 2025-03-31
PIs
3

Awarded at UNIVERSITY OF CALIFORNIA LOS ANGELES

NIH #U01EB026421

Non-Invasive Prenatal Diagnostics Based on Circulating Trophoblasts

Amount
$800K–$900K
Period
2019-08-15 → 2024-07-31
PIs
2

Awarded at UNIVERSITY OF CALIFORNIA LOS ANGELES

NIH #R21CA240887

Biomimetic NanoVilli Chips for Extracellular Vesicles in Hepatocellular Carcinoma

Amount
$200K–$300K
Period
2020-04-01 → 2023-03-31
PIs
3

Awarded at UNIVERSITY OF CALIFORNIA LOS ANGELES

NIH #R21CA235340

Click Chemistry-Mediated Microfluidic Sorting for HCC CTCs

Amount
$200K–$300K
Period
2019-04-02 → 2023-03-31
PIs
3

Awarded at UNIVERSITY OF CALIFORNIA LOS ANGELES

NIH #R01CA218356

A blood test to identify prostate cancer patients at risk for visceral metastasis

Amount
$600K–$700K
Period
2017-06-19 → 2022-05-31
PIs
2

Awarded at CEDARS-SINAI MEDICAL CENTER

NIH #U01CA198900

Thermoresponsive NanoVelcro CTC Purification System for Prostate Cancer Profiling

Amount
$400K–$500K
Period
2015-08-18 → 2020-07-31
PIs
2

Awarded at UNIVERSITY OF CALIFORNIA LOS ANGELES

NIH #P01CA168585

MICROFLUIDIC DIAGNOSTICS FOR MONITORING OF BRAF INHIBITOR RESISTANCE IN MELANOMA

Amount
$400K–$500K
Period
— → 2019-06-30
PIs
1

Awarded at UNIVERSITY OF CALIFORNIA LOS ANGELES

NIH #R44CA180482

CTC Purification System Based on Thermoresponsive NanoSubstrates

Amount
$900K–$1000K
Period
2013-09-19 → 2017-08-31
PIs
3

Awarded at CYTOLUMINA TECHNOLOGIES CORPORATION, INC

NIH #R33CA174562

Molecular and Functional Analysis of Single Circulating Melanoma Cells

Amount
$300K–$400K
Period
2013-05-01 → 2016-04-30
PIs
1

Awarded at UNIVERSITY OF CALIFORNIA LOS ANGELES

NIH #R21EB016270

Supramolecular Nanoparticle-Based PET Probes for Pretargeted Tumor Imaging

Amount
$200K–$300K
Period
2012-12-15 → 2014-11-30
PIs
1

Awarded at UNIVERSITY OF CALIFORNIA LOS ANGELES

NIH #R33CA157396

Advanced Development of An Integrated CTC Enrichment Technology

Amount
$200K–$300K
Period
2011-09-14 → 2014-08-31
PIs
1

Awarded at UNIVERSITY OF CALIFORNIA LOS ANGELES

Recent Public Signals

  1. New paper: Detection of Extracellular Vesicles with Colocalized Surface Markers via a Capture–Release–Capture Strategy for Treatment Monitoring in Ewing Sarcoma (Advanced Healthcare Materials)2026-02-22
  2. New NIH award: Translational development of osteosarcoma (OS) extracellular vesicle (EV) matrix metalloproteinase (MMP) Activity Assay for assessing patient treatment responses2025-09-01
  3. New preprint: Supplemental Table 4 from Emerin Dysregulation Drives the Very-Small-Nuclear Phenotype and Lineage Plasticity That Associate with a Clinically Aggressive Subtype of Prostate Cancer2025-05-15

Are you this professor?

No account needed — verify once with your ORCID iD to set recruiting status and correct your rank.

Data Freshness

  • Publications as of 2026-07-09
  • Grants as of 2026-09-03

Data may not be current

Find elsewhere

Institution / lab homepage Search on ResearchGate

ORCID: 0000-0003-0942-5905

Professor Insights

Career Trajectory